| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,268,249 |
|
|
|
Indirect Value
|
$149,961,660 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$151,229,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-05-14 |
4 |
AS |
$80.24 |
$7,258,752 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-08-01 |
4 |
S |
$60.43 |
$7,261,322 |
D/D |
(120,000) |
518,581 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-04-15 |
4 |
AS |
$103.06 |
$7,268,627 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-06-16 |
4 |
AS |
$80.90 |
$7,280,784 |
D/D |
(90,000) |
119,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-02-14 |
4 |
AS |
$81.17 |
$7,322,222 |
D/D |
(90,000) |
68,124 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-05-15 |
4 |
AS |
$109.12 |
$7,661,533 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-09-15 |
4 |
AS |
$109.60 |
$7,749,195 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-07-24 |
4 |
S |
$52.07 |
$7,810,530 |
D/D |
(150,000) |
1,076,525 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-15 |
4 |
AS |
$117.72 |
$7,832,152 |
D/D |
(66,261) |
168,907 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-02-14 |
4 |
S |
$59.02 |
$8,064,332 |
D/D |
(136,488) |
518,581 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-08-17 |
4 |
AS |
$115.70 |
$8,131,019 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-06-15 |
4 |
AS |
$116.98 |
$8,237,002 |
D/D |
(70,000) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-07-24 |
4 |
S |
$48.00 |
$8,661,324 |
D/D |
(180,448) |
1,050,156 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
D |
$103.84 |
$8,669,602 |
D/D |
(83,490) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-02-04 |
4 |
S |
$52.43 |
$9,096,634 |
D/D |
(173,452) |
1,076,525 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-02-09 |
4 |
S |
$71.20 |
$9,540,214 |
D/D |
(133,920) |
525,381 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-05-02 |
4 |
S |
$83.80 |
$10,060,010 |
D/D |
(120,000) |
525,381 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2007-10-26 |
4 |
S |
$46.00 |
$10,136,507 |
D/D |
(220,000) |
1,031,553 |
0 |
- |
|
193 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
